Prashant Upadhyay

Dr. Prashant Upadhyay


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2022 in Oriental Journal of Chemistry
Verified
Journal Article
Open access
PDF file
PMPooja Malik
Pooja Malik
PUPrashant Upadhyay
Prashant Upadhyay
The present investigation aimed to determine the oxidative potential, sun protection factor value, and half-maximal inhibitory concentration of rosemary essential oil and tea tree essential oil. These two essential oils have gained popularity as active ingredients in many cosmetic preparations due to their antioxidant activity, whether used individually or in combination. Gas chromatography-mass spectroscopy is used to identify the presence of different phytochemical constituents in essential oils. The GC-MS (Gas chromatography-mass spectroscopy) chemical analysis of tea tree oil revealed 34 and rosemary oil revealed 35 volatile chemical components with sesquiterpene hydrocarbon, monoterpenes (42.77%), and alcohols (41.01%) as major detected classes. The 2, 2-diphenylpicrylhydrazyl (DPPH) and nitric oxide-free scavenging activity techniques were used to investigate the antioxidant capacity of these oils. It was found that both tea tree and rosemary oil have the potential to slow down skin aging through their anti-oxidative properties using the approach of free radical scavenging activity. The UV spectroscopy method was used to determine the sun protection factor, and the sun protection values of rosemary and tea tree oil were found to be 8.45 and 6.85, respectively. Rosemary oil was an extremely promising tea tree essential oil for anti-aging and sunburn prevention. The study's findings indicated that rosemary and tea tree essential oil can both offer a synergistic sun protection factor effect, antioxidant property, and anti-aging or extra activity of cosmetic preparations.

1 August 2023 in Current Drug Therapy
Verified
Journal Article
Closed access
PDF file
PUPrashant Upadhyay
Prashant Upadhyay
PMPooja Malik
Pooja Malik
SUSukirti Upadhyay
Sukirti Upadhyay
The tea tree (Melaleuca alternifolia), a member of the Myrtaceae family, is a valuable medicinal and aromatic plant. Tea Tree essential oil (TTO) has many medical applications, including antibacterial, antifungal, antiviral, antiprotozoal, anti-inflammatory, antioxidant, and anticancer properties. Although the concentration of TTO in a microemulsion is of economic interest, very few studies on this product have been conducted. In this study, we look at how different tea tree oil concentrations in microemulsion formulations affect susceptibility to various bacteria and fungi. TTO susceptibility in a diverse range of microbial species has now been studied using data from a previously published literature review survey. Most bacteria are resistant to TTO at concentrations as low as 1.0 percent, but mucosal skin staphylococci and micrococci, Enterococcus faecalis, and Pseudomonas aeruginosa have minimum inhibitory concentrations much higher than 2 percent. TTO susceptibility in fungi has only recently been scrutinized. Fungicidal dosages range from 0.12 to 2 percent, with minimum inhibitory concentrations ranging from 0.03 to 0.5 percent and the only notable exception is Aspergillus niger, which contains fungicidal concentrations of up to 8%. The review emphasizes the importance of new antibacterial and antifungal formulations, as well as the role of natural essential oils in the discovery of new antibacterial and antifungal agents, and discusses, in brief, all constituents derived from the essential oil (tea tree) that are in preclinical and clinical development. This paper summarizes human and food-borne bacteria and fungi susceptibility to tea tree essential oils and their constituents. Among the many tested, essential oils of spices and herbs (Melaleuca alternifolia) were found to have the strongest antimicrobial properties. This review looks at a wide range of scientific literature, including Sci-hub, Google Scholar, Pub, Chem, NCBI, and web books.

1 June 2014 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
PUPrashant Upadhyay
Prashant Upadhyay
JPJayanta Kumar Pandit
Jayanta Kumar Pandit
AWArun Kumar Wahi
Arun Kumar Wahi

1 June 2024 in Current Molecular Medicine
Verified
Journal Article
Closed access
PDF file
PUPrashant Upadhyay
Prashant Upadhyay
RARamsha Aslam
Ramsha Aslam
VTVarsha Tiwari
Varsha Tiwari
SUSukirti Upadhyay
Sukirti Upadhyay
The development of nanosized drug-carrier systems has been investigated over the past few decades using various techniques. The two main categories of these systems are polymeric nanoparticles and lipid nanoparticles (LNPs). The toxicological risk associated with lipid nanoparticles is significantly lower than the danger associated with polymeric nanoparticles due to the materials' natural and biological origins. Lipid-based drug delivery systems like Nanostructured lipid carriers (NLCs) and Solid Lipid Nanoparticles (SLNs) are well-established nanotechnology systems for preparing all major pharmaceuticals. These delivery systems can be scaled up with easy manufacturing procedures and are biocompatible. NLCs are the second generation of lipid-based nanocarriers (SLNs), formed by combining solid and liquid biocompatible lipids to form an unstructured matrix that provides high entrapment efficiency of active constituents. LNPs can promote the distribution of active pharmaceutical ingredients to the target site. Increasing the active drug concentration to target organ LNPs enhances the therapeutic effectiveness and reduces the side effects. This paper reviews the structure of SLNs and different NLCs, various steps involved in manufacturing lipid nanoparticles, excipients used in the formulation, and applications for targeted drug delivery.

1 December 2022 in Recent Advances in Drug Delivery and Formulation
Verified
Journal Article
Closed access
PDF file
PUPrashant Upadhyay
Prashant Upadhyay
DSDeepak Singh
Deepak Singh
SUSukirti Upadhyay
Sukirti Upadhyay
Phytoconstituents have been used to treat a variety of human diseases for a long time, but their use in pharmaceuticals is limited because of their low aqueous solubility. Researchers have created vesicular systems to address many of the issues associated with the bioavailability and therapeutic efficacy of poorly water-soluble drugs and target the drug to the desired location in the body. Several vesicular nanocarrier systems have been developed. Review contrasts various vesicular drug delivery systems, including liposomes, sphingosomes, emulsomes, niosomes, ethosomes, virosomes, phytosomes, aquasomes, proniosomes, transfersomes, pharmacosomes. Vesicular drug delivery systems have caused a scientific revolution, which has resulted in the development of novel dosage forms. This review aims to illustrate the applications, advantages, and disadvantages of the vesicular approach as nanocarriers bearing curcumin and widely used in gene delivery, tumor-targeting to the brain, oral formulations, and resolving various problems associated with drug stability and permeability issues. Nanocarriers also has wide application as green nanocomposites and for antitubercular drugs depending on their physical properties.

7 January 2024 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
RARamsha Aslam
Ramsha Aslam
VTVarsha Tiwari
Varsha Tiwari
PUPrashant Upadhyay
Prashant Upadhyay
Abhishek TiwariAbhishek Tiwari
Abhishek Tiwari
Objective: The pharmaceutical industry has paid a lot of attention to solid lipid nanoparticles (SLN) because they show promise as drug delivery vehicles. The purpose of this research was to create and characterize SLN loaded with Diosgenin. Methods: To create SLN, the natural bioactive component diosgenin was encapsulated in a solid lipid matrix of compritol ATO 888. A modified solvent emulsification-evaporation process was used to create the SLN. Using a Box-Behnken Design (BBD), we were able to identify the optimal values for the drug-to-solid lipid ratio, surfactant concentration, and ultrasonication period that constitute an effective formulation. Results: It was found that the improved formulation had particle sizes of 170.96 nm, polydispersity indices (PDI) of 0.231, and entrapment efficiencies of 64.549±0.553% %. The zeta potential value of -40.2 mV was indicative of a steady dispersion. The average particle size of the SLN was measured to be 103.1429 nm, and their spherical morphology was validated by scanning electron microscopy (SEM) imaging. The optimized formulation did not undergo any chemical changes, as shown by differential scanning calorimetry (DSC) testing. The in vitro drug release investigation showed that the SLN released Diosgenin continuously for 28 h. Conclusion: The optimized formulation of SLN, achieved through the BBD, offers a promising strategy to improve drug solubility while ensuring controlled drug release and long-term storage stability.